X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1116) 1116
Publication (55) 55
Book Chapter (16) 16
Reference (10) 10
Conference Proceeding (8) 8
Paper (6) 6
Book Review (5) 5
Book / eBook (3) 3
Dissertation (3) 3
Magazine Article (2) 2
Government Document (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
astatine (702) 702
indium (390) 390
beryllium (341) 341
arsenic (278) 278
animals (192) 192
humans (171) 171
mice (152) 152
nuclear physics and radiation physics (136) 136
iodine (134) 134
astatine - therapeutic use (126) 126
radioimmunotherapy (121) 121
radioisotopes (92) 92
isotopes (84) 84
radiology, nuclear medicine & medical imaging (83) 83
energy levels (82) 82
operations research (81) 81
tissue distribution (81) 81
astatine isotopes (80) 80
female (79) 79
nuclei (77) 77
alpha particles (74) 74
companies (74) 74
decay (71) 71
index medicus (70) 70
astatine-211 (69) 69
astatine - chemistry (67) 67
astatine - pharmacokinetics (62) 62
alpha decay radioisotopes (61) 61
conductors (61) 61
heavy nuclei (61) 61
nuclear data collections (61) 61
at-211 (58) 58
beta decay radioisotopes (58) 58
mice, nude (58) 58
paper (58) 58
nuclear structure (56) 56
circuit faults (54) 54
astatine 211 (52) 52
mice, inbred balb c (52) 52
switches (52) 52
physics (51) 51
oncology (50) 50
surges (50) 50
bismuth isotopes (49) 49
equations (49) 49
nndc (49) 49
polonium isotopes (49) 49
therapy (49) 49
radioimmunotherapy - methods (48) 48
radiotherapy (48) 48
spin (48) 48
antibodies, monoclonal - therapeutic use (47) 47
chemistry (46) 46
electron capture radioisotopes (46) 46
generators (46) 46
computers (45) 45
odd-even nuclei (45) 45
cell line, tumor (43) 43
controller area networks (43) 43
half-life (43) 43
insulation (43) 43
alpha particles - therapeutic use (42) 42
beta-minus decay radioisotopes (42) 42
parity (42) 42
hours living radioisotopes (40) 40
male (40) 40
relays (40) 40
lead isotopes (39) 39
minutes living radioisotopes (39) 39
antibodies (37) 37
cancer (37) 37
energy-level transitions (37) 37
seconds living radioisotopes (37) 37
physics, nuclear (36) 36
nuclear decay (35) 35
radon isotopes (35) 35
rats (35) 35
angular momentum (34) 34
dosimetry (34) 34
radiopharmaceuticals - therapeutic use (33) 33
tumor cells, cultured (33) 33
alpha decay (32) 32
francium isotopes (32) 32
isotope labeling (32) 32
neoplasms - radiotherapy (32) 32
nuclear science & technology (32) 32
particle properties (32) 32
plants (32) 32
arresters (31) 31
bismuth (31) 31
corona (31) 31
data (31) 31
monoclonal-antibody (31) 31
nuclear reactions (31) 31
power cables (31) 31
substations (31) 31
chemistry, inorganic & nuclear (30) 30
economics (30) 30
astatine - administration & dosage (29) 29
circuit breakers (29) 29
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature, ISSN 0028-0836, 03/2019, Volume 567, Issue 7748, pp. 311 - 311
Journal Article
Physical Review C, ISSN 2469-9985, 09/2016, Volume 94, Issue 3
A nuclear-decay spectroscopy study of the neutron-deficient isotope At-196 is reported where an isotopically pure beam was produced using the selective... 
ASTATINE | PHYSICS, NUCLEAR | STATES
Journal Article
Nature Chemistry, ISSN 1755-4330, 03/2013, Volume 5, Issue 3, pp. 246 - 246
Journal Article
Physical Chemistry Chemical Physics : PCCP, ISSN 1463-9076, 01/2019, Volume 21, Issue 28, pp. 15310 - 15318
Theoretical studies on the dimers formed by CO with the halides of multivalent astatine as a Lewis-acid center are carried out to examine the typical... 
Lewis acid | Astatine | Halides | Bonding strength | Dimers
Journal Article
Nuclear medicine and biology, ISSN 0969-8051, 05/2017, Volume 48, pp. 31 - 35
The availability of At for targeted alpha therapy research can be increased by the Rn/ At generator system, whereby At is produced by Rn electron capture... 
Radon - chemistry | Astatine - chemistry | Astatine - isolation & purification | Astatine - therapeutic use | Immunoconjugates - therapeutic use | Isotope Labeling | Alpha Particles - therapeutic use | Radiochemistry - instrumentation
Journal Article
1985, 8th ed., Gmelin handbook of inorganic chemistry, ISBN 9783540935162, Volume system no. 8 a., xiii, 291
Book
NUCLEAR MEDICINE AND BIOLOGY, ISSN 0969-8051, 03/2017, Volume 46, pp. 43 - 49
Journal Article
Chemistry – A European Journal, ISSN 0947-6539, 08/2016, Volume 22, Issue 35, pp. 12201 - 12201
Despite 75 years having passed since its discovery, the heaviest halogen and one of the rarest of all elements, astatine, apparently still has surprises in... 
radiopharmaceuticals | iodonium salts | halogenation | astatine | nucleophilic substitution
Journal Article
Nature, ISSN 0028-0836, 03/2019, Volume 567, Issue 7748, pp. 311 - 311
Journal Article
Molecules, ISSN 1420-3049, 2018, Volume 23, Issue 3, p. 581
This review summarizes recent progress and developments as well as the most important pitfalls in targeted alpha-particle therapy, covering single... 
In vivo generators | Targeted alpha therapy | Astatine | Nuclear recoil | Decay | Actinium | Bismuth | 223Ra | Alpha particle | Radium | SEPARATION TECHNOLOGY | radium | actinium | nuclear recoil | EFFICACY | DRUG-DELIVERY | BIOCHEMISTRY & MOLECULAR BIOLOGY | alpha particle | RADIUM-223 | decay | Ra-223 | RADIATION | CHEMISTRY, MULTIDISCIPLINARY | NANOPARTICLES | astatine | RADIONUCLIDE THERAPY | PROSTATE-CANCER | targeted alpha therapy | in vivo generators | DOSIMETRY | bismuth | Humans | Drug Carriers - administration & dosage | Bismuth - therapeutic use | Alpha Particles - therapeutic use | Drug Carriers - chemistry | Bismuth - chemistry | Chelating Agents - pharmacokinetics | Heterocyclic Compounds - chemistry | Heterocyclic Compounds, 1-Ring - chemistry | Actinium - therapeutic use | Astatine - therapeutic use | Neoplasms - radiotherapy | Radioisotopes - therapeutic use | Radiopharmaceuticals - chemistry | Heterocyclic Compounds, 1-Ring - pharmacokinetics | Chelating Agents - chemistry | Radiation Dosage | Radium - therapeutic use | Radium - chemistry | Small Molecule Libraries - chemistry | Actinium - chemistry | Astatine - chemistry | Heterocyclic Compounds - pharmacokinetics | Neoplasms - pathology | Small Molecule Libraries - pharmacokinetics | Dose-Response Relationship, Radiation | Radioisotopes - chemistry | Radiopharmaceuticals - therapeutic use | Medical research | Therapy | Alpha rays | Clinical trials | Radioisotopes | Labelling | Recoil | Generators | Organic chemistry | Bismuth isotopes | Radiochemistry | Chelating agents | Emitters | Nuclides | Cancer | Pharmaceuticals
Journal Article
Physical Review C - Nuclear Physics, ISSN 0556-2813, 02/2009, Volume 79, Issue 2
Journal Article
The Journal of Physical Chemistry A, ISSN 1089-5639, 01/2010, Volume 114, Issue 1, pp. 576 - 582
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2007, Volume 69, Issue 2, pp. 572 - 579
Purpose To investigate the potential use of astatine-211 (211 At)-labeled trastuzumab for the treatment of HER-2–positive, radioresistant ovarian carcinoma.... 
Radiology | Hematology, Oncology and Palliative Medicine | Astatine | Nude mice | α-Particles | Trastuzumab | Radioimmunotherapy | FRACTIONATED RADIOIMMUNOTHERAPY | alpha-particles | OVARIAN-CANCER | trastuzumab | GROWTH-FACTOR RECEPTOR | BREAST-CANCER CELLS | IN-VITRO | ONCOLOGY | astatine | RESISTANCE | nude mice | MONOCLONAL-ANTIBODIES | HER2 | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | AT-211-MX35 F(AB') | Radiotherapy Dosage | Ovarian Neoplasms - chemistry | Humans | Radiation Tolerance | Ovarian Neoplasms - pathology | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Ovarian Neoplasms - radiotherapy | Astatine - administration & dosage | Antibodies, Monoclonal, Humanized | Animals | Antibodies, Monoclonal - administration & dosage | Mice, Nude | Astatine - therapeutic use | Cell Line, Tumor | Radioimmunotherapy - methods | Female | Mice | Mice, Inbred BALB C | Receptor, ErbB-2 | Health aspects | Radiation | Tumors | ANTIBODIES | ALPHA PARTICLES | ASTATINE 211 | RADIOIMMUNOTHERAPY | ASTATINE | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | MICE | RADIATION DOSES | DOSE-RESPONSE RELATIONSHIPS | Inbred BALB C | pathology | methods | Antibodies | Nude | administration & dosage | Radiology, Nuclear Medicine and Medical Imaging | Tumor | Monoclonal | Ovarian Neoplasms | chemistry | Cell Line | Radiologi och bildbehandling | Antineoplastic Agents | Receptor | radiotherapy | Cancer and Oncology | therapeutic use | Cancer och onkologi | erbB-2
Journal Article
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, ISSN 0969-8043, 04/2017, Volume 122, pp. 222 - 228
Mass-separated francium beams ( Fr or Fr) were implanted into solid targets for producing Rn (14.6h half-life) or At (5.41h), in situ. Rn was transferred to... 
Diagnostic Imaging - methods | Radon - chemistry | Water | Molecular Weight | Astatine - chemistry | Solutions | Francium - chemistry | Astatine - therapeutic use | Half-Life
Journal Article
Journal Article
Chemistry – A European Journal, ISSN 0947-6539, 08/2016, Volume 22, Issue 35, pp. 12205 - 12205
Invited for the cover of this issue is the group of François Guérard at the University of Nantes, in collaboration with scientists at the National Institutes... 
Finishes | Astatine | Health | Halogens | Cooperation | Race | Texts | Scientists
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.